Aspiro (Aspiro)
Lacosamide Injection
Product Images NDC 31722-203
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 31722-203). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Camberlogo (Camberlogo)
Lacosamide-carton-label-10-mg-ml (Lacosamide Carton Label 10 mg mL)
Packaging label for Lacosamide Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Camber Pharmaceuticals, Inc. The carton contains 10 single-dose 20 mL vials. Manufactured by Aspiro Pharma Limited in India. The label includes storage instructions, inactive ingredients, and dosing guidance references.*
Lacosamide-figure-1 (Lacosamide Figure 1)
Bar chart comparing seizure reduction percentages across three studies for Lacosamide injection at various dosages versus placebo. The y-axis represents median percent change in baseline seizure reduction, with Lacosamide doses of 200, 400, and 600 mg/day showing higher seizure reduction compared to placebo in Studies 2, 3, and 4. Sample sizes for each group are indicated below the x-axis.*
Lacosamide-figure-2 (Lacosamide Figure 2)
A responder rate curve chart showing the percentage of patients with equal or greater improvement on the vertical axis and percent of patients on the horizontal axis. It compares placebo with Lacosamide at doses of 200 mg/day, 400 mg/day, and 600 mg/day, illustrating patient response rates for each group in a clinical context.*
Lacosamide-structure (Lacosamide Structure)
Chemical structure diagram of lacosamide, showing its molecular framework including functional groups such as an amide, methoxy groups, and a benzyl moiety. This illustration corresponds to the active ingredient lacosamide used in pharmaceutical formulations.*
Lacosamide-vial-label-10-mg-ml (Lacosamide Vial Label 10 mg mL)
Lacosamide Injection USP 200 mg per 20 mL (10 mg/mL) single-dose vial label for intravenous use. The label shows the product name, strength, dosage form, route, and manufacturer details. It includes storage instructions and a barcode. Manufactured by Aspiro Pharma Limited, India, for Camber Pharmaceuticals, Inc.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
